Sub-group | N | Sample size | I2 | Egger test | Prevalence (95% CI) | |
---|---|---|---|---|---|---|
Study type | Cross-sectional | 47 | 115,281 | 99.02 | 0.016 | 24.8 (95%CI: 21.9–28) |
Cohort | 4 | 172,408 | 99.9 | 0.055 | 13 (95%CI: 2.3–48.4) | |
Continent | America | 6 | 171,727 | 99.8 | 0.042 | 13.1 (95%CI: 3.3–39.9) |
Africa | 7 | 2422 | 97.5 | 0.556 | 26.4 (95%CI: 15.4–41.6) | |
Europe | 3 | 5273 | 26.8 | - | 20.5 (95%CI: 19.3–21.8) | |
Asia | 35 | 108,267 | 99.2 | 0.024 | 25.4 (95%CI: 22-29.1) |